References: Nslund E, Gutniak M, Skogar S, Rssner S, Hellstrm PM
GLP-1 receptor agonists are approved by the FDA for managing type 2 diabetes, as well as for obesity or overweight individuals with obesity-related conditions such as high cholesterol or nonalcoholic fatty liver disease
They are not something you buy from an Instagram ad and slap on your arm
Risks of Untreated Constipation While constipation might seem like a minor inconvenience, untreated or chronic constipation can lead to more serious health issues, including: Bowel Obstruction: Chronic constipation can cause a blockage in your intestines, leading to painful and potentially dangerous conditions
These results serve as a foundation for detecting any changes over time
Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial